BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17150294)

  • 1. Refractory psychosis and prominent cognitive deficits in a patient with mega-cisterna magna.
    Ferentinos PP; Kontaxakis VP; Havaki-Kontaxaki BJ; Paplos KG; Pappa DA; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):561-3. PubMed ID: 17150294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dandy-Walker syndrome with psychotic symptoms: a case report.
    Buonaguro EF; Cimmarosa S; de Bartolomeis A
    Riv Psichiatr; 2014; 49(2):100-2. PubMed ID: 24770576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychosis associated to megacisterna magna].
    Langarica M; Peralta V
    An Sist Sanit Navar; 2005; 28(1):119-21. PubMed ID: 15827586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of isolated mega cisterna magna.
    Zimmer EZ; Lowenstein L; Bronshtein M; Goldsher D; Aharon-Peretz J
    Arch Gynecol Obstet; 2007 Nov; 276(5):487-90. PubMed ID: 17453222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric manifestations associated with mega cisterna magna.
    Pandurangi S; Pandurangi A; Matkar A; Shetty N; Patil P
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):169-71. PubMed ID: 24763763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of cognitive and fine motor deficits in a case of Dandy-Walker continuum.
    Economou A; Katsetos CD
    J Child Neurol; 2012 Jul; 27(7):930-7. PubMed ID: 22241712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manic episode associated with mega cisterna magna.
    Turan T; Beşirli A; Asdemir A; Ozsoy S; Eşel E
    Psychiatry Investig; 2010 Dec; 7(4):305-7. PubMed ID: 21253417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment predictors of cognitive deficits in early psychosis.
    González-Blanch C; Crespo-Facorro B; Alvarez-Jiménez M; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Barquero JL
    Psychol Med; 2008 May; 38(5):737-46. PubMed ID: 17922942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical psychotic symptoms and Dandy-Walker variant.
    Williams AJ; Wang Z; Taylor SF
    Neurocase; 2016 Oct; 22(5):472-475. PubMed ID: 27662527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of cognitive and affective development in cerebellar malformations.
    Tavano A; Grasso R; Gagliardi C; Triulzi F; Bresolin N; Fabbro F; Borgatti R
    Brain; 2007 Oct; 130(Pt 10):2646-60. PubMed ID: 17872929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dandy-Walker malformation associated with polycystic kidneys: Goldston syndrome revisited.
    Menon RK; Nadkarni TD; Desai KI; Goel A
    J Clin Neurosci; 2006 Oct; 13(8):875-7. PubMed ID: 16931025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar cognitive affective syndrome in Dandy-Walker variant disorder.
    Graf H; Franke B; Abler B
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E45-6. PubMed ID: 24026741
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive alterations in groups at risk for psychosis: neutral markers of genetic risk or indicators of social disability?
    Jabben N; van Os J; Janssen I; Versmissen D; Krabbendam L
    Acta Psychiatr Scand; 2007 Oct; 116(4):253-62. PubMed ID: 17803755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
    Lee SW; Lee JG; Lee BJ; Kim YH
    Int Clin Psychopharmacol; 2007 Mar; 22(2):63-8. PubMed ID: 17293705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors.
    Pogge DL; Insalaco B; Bertisch H; Bilginer L; Stokes J; Cornblatt BA; Harvey PD
    Psychiatry Res; 2008 Jul; 160(1):47-54. PubMed ID: 18534688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
    Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A
    Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset psychosis associated with dandy-walker variant in an adolescent female patient.
    Ryan M; Grenier E; Castro A; Nemeroff CB
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):241-6. PubMed ID: 22772673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive decline following psychosis onset: data from the PACE clinic.
    Wood SJ; Brewer WJ; Koutsouradis P; Phillips LJ; Francey SM; Proffitt TM; Yung AR; Jackson HJ; McGorry PD; Pantelis C
    Br J Psychiatry Suppl; 2007 Dec; 51():s52-7. PubMed ID: 18055938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.